Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Teva Pharmaceutical Industries ( TEVA) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.9%. By the end of trading, Teva Pharmaceutical Industries fell $0.39 (-1.0%) to $38.51 on heavy volume. Throughout the day, 5,435,666 shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 3,556,200 shares. The stock ranged in price between $38.30-$38.79 after having opened the day at $38.56 as compared to the previous trading day's close of $38.90. Other companies within the Health Care sector that declined today were: Pingtan Marine Enterprise ( PME), down 82.5%, Mast Therapeutics ( MSTX), down 40.0%, Escalon Medical Corporation ( ESMC), down 10.1% and Prima Biomed ( PBMD), down 8.8%.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. Teva Pharmaceutical Industries has a market cap of $33.6 billion and is part of the drugs industry. Shares are up 5.6% year to date as of the close of trading on Friday. Currently there are 9 analysts that rate Teva Pharmaceutical Industries a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Teva Pharmaceutical Industries as a hold. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself.

On the positive front, Spherix ( SPEX), up 100.4%, Compugen ( CGEN), up 44.5%, Inovio Pharmaceuticals ( INO), up 44.2% and Aastrom Biosciences ( ASTM), up 31.1% , were all gainers within the health care sector with Aetna ( AET) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists